Copyright © 2021. Inderes Oyj. All rights reserved.

Nightingale

Viimeisimmät raportit

Laaja raportti

Analyst

Antti Luiro

Antti Luiro

Analyytikko

Read more

Latest insider trading

Net impact profile

Tiedotteet
19.5.
2022

Company release, 19 May 2022 at 5.35 p.m. (EEST)

The Board of Directors of Nightingale Health Plc has in its meeting on February 2, 2022 and April 14, 2022, approved request of shareholders to convert 730,828 Series A and 280,537 EMP shares of Nightingale Health Plc to Series B shares in accordance with Article 5 in the Articles of Association.

Analyst comment
31.3.
2022

As expected, Nightingale Health announced the launch of the new Livit by Nightingale consumer service.

Tiedotteet
18.3.
2022

Company release, 18 March 2022 at 9:45 (EET)

Analyysi
25.2.
2022

Commercialization of Nightingale’s technology is still progressing on a broad front. The story combining the company’s high risks and potential has, in our opinion, only strengthened after the IPO. Pricing of future promises has fallen dramatically as the time horizon has shortened on the market, which is also reflected in Nightingale. Concrete supporting points for the company's valuation can in the short term already be found in the balance sheet focusing on cash (2022e P/B 1.2x). 

Analyst comment
24.2.
2022

Nightingale’s fiscal year H1 report (7/1/21-12/31/21) was in line with expectations.

Tiedotteet
24.2.
2022

Nightingale Health Plc Half-year report 1 July 2021 - 31 December 2021 (unaudited)

Nightingale Health Group's Half-year report: Progressing faster than expected in line with strategy

Company Release, 24 February 2022 at 9:00 a.m. (EET)

This release is a summary of Nightingale Health Plc's Half-year report from period 1 July 2021 - 31 December 2021. The full Half-year report is attached to this release.

Numbers presented in brackets refer to corresponding year-on-year period unless otherwise stated.

Analyst comment
22.2.
2022

Since its listing a year ago, Nightingale has actively worked on the commercialization of its technology. Construction of Nightingale’s business is currently progressing on several fronts and our attention is focused on signs that these projects are progressing.

Tiedotteet
16.2.
2022

Press release, 16 February 2022 at 12 p.m. (EET)

Nightingale Health Plc will publish its half-year report for July - December 2021 on 24 February 2022 at around 9 a.m. EET. The materials will be made available soon after publication at www.nightingalehealth.com/investors.

Tiedotteet
8.2.
2022

Company release, 8 February 2022 at 4:00 p.m. (EET)

The Board of Directors of Nightingale Health Plc ("Nightingale") has in its meeting on November 8, 2021, approved a request of shareholders to convert 661,246 Series A shares of Nightingale to Series B shares in accordance with Article 5 in the Articles of Association.

Nightingale

ipo